Exelixis (EXEL) Tops Q4 EPS by 10c, FY Revenue Guidance Misses
Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.26, $0.10 better than the analyst estimate of $0.16. Revenue for the quarter came in at $240.3 million versus the consensus estimate of $240.52 million.
GUIDANCE:
Exelixis sees FY2020 revenue of $850-900 million, versus the consensus of $944 million.
Total revenues |
| $850 million - $900 million |
Net product revenues |
| $725 million - $775 million |
Cost of goods sold |
| 4% - 5% of net product revenues |
Research and development expenses(1) |
| $460 million - $500 million |
Selling, general and administrative expenses(2) |
| $230 million - $250 million |
Effective tax rate |
| 20% - 22% |
Cash and investments(3) |
| $1.5 billion - $1.6 billion |
For earnings history and earnings-related data on Exelixis (EXEL) click here.